Osteora
Osteora
Explore our premium range of CE-certified implants and precision surgical instruments engineered for optimal clinical outcomes.
Total Knee Arthroplasty (TKA) has evolved into one of the most successful surgical procedures in modern medicine, dramatically improving the quality of life for patients suffering from severe osteoarthritis, rheumatoid arthritis, and post-traumatic joint degeneration. As a premier CE Certified Total Knee Implants Exporter, Osteora delivers clinical-grade joint reconstruction systems designed to withstand physiological loading while preserving native biomechanics.
Our comprehensive joint systems prioritize advanced material science and kinematic harmony. We address the primary failure modes of knee arthroplasty—specifically wear debris, aseptic loosening, and joint instability—by utilizing biocompatible Cobalt-Chromium-Molybdenum (CoCrMo) femoral components, Ultra-High-Molecular-Weight Polyethylene (UHMWPE) articulating inserts, and medical-grade Titanium Alloy (Ti6Al4V) tibial platforms. This multi-material alignment mitigates friction, ensures low wear rates, and promotes long-term implant survivorship.
Osteora knee systems are engineered for both Cruciate-Retaining (CR) and Posterior-Stabilized (PS) surgical pathways, allowing orthopedic surgeons to select the ideal option based on the patient's posterior cruciate ligament status.
Osteora Medical Devices Co., Ltd. represents excellence in orthopedic manufacturing, merging precision engineering with robust global supply chains.
Osteora Medical Devices Co., Ltd. is a professional orthopedic implant and surgical solution manufacturer specializing in trauma, spine, and joint reconstruction systems under the brand Osteora. Founded in 2016, the company has developed a strong reputation in the global orthopedic industry through continuous innovation and strict quality control standards. The facility covers an area of approximately 18,500㎡, supporting integrated production, assembly, and testing operations.
With 8 years of export experience and 12 years of industry expertise, Osteora has established stable cooperation with international distributors and hospitals across multiple regions. Annual export revenue ranges from USD 6 million to 14 million, reflecting steady global market growth.
Our supply chain includes approximately 1,200 certified upstream and downstream partners, supporting stable production capacity and reliable delivery performance. Its main customer base consists of hospitals, orthopedic clinics, surgical centers, and medical distributors worldwide.
With strong R&D capabilities, Osteora operates an in-house engineering team of 85 R&D engineers, focusing on innovation in trauma fixation systems, spinal implants, and joint reconstruction technologies. The company offers extensive customization options, including OEM/ODM services, size variations, material customization, and private labeling. In the past year, Osteora launched approximately 120 new products, reflecting its continuous investment in innovation.
Every knee implant and surgical plate undergoes a rigorous, vertically integrated fabrication process inside our cleanroom-equipped facility.
Our machining floor utilizes top-tier equipment from Switzerland, USA, and Japan to achieve sub-micron dimensional accuracy.
Ensuring patient safety through comprehensive compliance validation including chemical, structural, and mechanical stress analysis.
The company implements comprehensive quality assurance systems, including ISO 13485 compliance, in-process inspection, and final random sampling testing. Product inspection methods include dimensional measurement, mechanical fatigue testing, and biocompatibility validation. The quality control team consists of 42 specialized inspectors ensuring strict adherence to international medical device standards.
Our quality verification processes leverage state-of-the-art laboratory hardware to measure shear stress limits, tensile elasticity, and fatigue life down to the millionth cycle (conforming to ISO 14243 wear standards for total knee joint prostheses).
Using gas spectrometry and hardness testers, we analyze chemical compositions and material integrity before processing. Surface roughness (Ra) values are maintained under 0.05 μm for articular surfaces to prevent polyethylene wear. Every batch receives full traceability certification back to the raw ingot mill test report (MTR).
Osteora maintains a deep trading background in global medical device distribution, optimizing the regulatory pathway for major importing markets. We hold long-term strategic agreements with implant distributors throughout Europe, Southeast Asia, the Middle East, and South America.
We recognize that clinical needs differ across regional cohorts. In the EU, compliance with the stringent Medical Device Regulation (MDR 2017/745) is essential. Osteora actively supports partners with comprehensive technical files, clinical evaluation reports (CER), and CE-certificate validation to ease localized regulatory submission. In Southeast Asia and Latin America, our modular sizing ensures compatibility with differing anatomical averages, allowing surgeons to minimize bone resection and achieve a anatomical fit.
As a global B2B supplier, we understand that brand localization drives market adoption. We offer a structured portfolio of customized services:
How Osteora is steering innovation towards smart, biological, and customized joint reconstruction technologies.
We are integrating selective laser melting (SLM) to fabricate trabecular structures on the bone-facing surfaces of tibial trays. This mimics natural cancellous bone, facilitating biological osseointegration and eliminating the need for bone cement.
To reduce oxidative degradation of the poly insert over time, our upcoming materials roadmap introduces Vitamin-E blending. This stabilizes free radicals, ensuring high impact strength and low friction for active patients.
By using preoperative CT/MRI scans, we fabricate custom 3D-printed cutting guides. This helps surgeons plan precise cuts, reducing surgical times and aligning with kinematic principles.
Technical and commercial answers to direct questions from surgical directors, regulatory officers, and orthopedic distributors.
Our total knee replacement systems are fabricated using implant-grade materials:
Osteora implants comply with ISO 13485 quality standards. Our product catalog carries Class III CE certifications, enabling direct import to the EU and regions recognizing CE clearance. We provide full technical documentation, sterilization validation reports (gamma irradiation), and biocompatibility datasets to streamline local regulatory filings.
Yes. Our knee system is designed to support both CR and PS surgical techniques. The CR system features a conservative design that preserves the posterior cruciate ligament, while the PS system includes an advanced cam-and-post mechanism to provide stability in cases of ligament deficiency.
MOQ varies based on customization level (e.g., custom sizes, materials, or custom branding). Typically, OEM projects require a minimum run of 50–100 units per size specification, with a lead time of 45–60 days, covering tooling setup, high-precision HAAS CNC machining, ultrasonic cleaning, and sterile packaging.
Our implants undergo fatigue testing on our Multifunctional Mechanical Testing machines, conforming to ISO 14243. We subject our femoral and tibial components to simulated loading cycles exceeding 5 million cycles, ensuring the implant retains stability over decades of patient activity.
Discover our complementary trauma fixation plates, spinal instruments, and power tool systems for comprehensive surgical solutions.
